Annual CAPEX
N/A
30 April 2024
Summary:
KalVista Pharmaceuticals annual capital expenditures is not available.KALV CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly capital expenditures is not available.KALV Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
31 July 2024
Summary:
KalVista Pharmaceuticals TTM capital expenditures is not available.KALV TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
KALV CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
KalVista Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2020 | $220.00 K(-79.6%) | $8000.00(>+9900.0%) | $220.00 K(-54.8%) |
| Jan 2020 | - | $0.00(-100.0%) | $487.00 K(-3.9%) |
| Oct 2019 | - | $114.00 K(+16.3%) | $507.00 K(-17.4%) |
| July 2019 | - | $98.00 K(-64.4%) | $614.00 K(-43.2%) |
| Apr 2019 | $1.08 M(-24.2%) | $275.00 K(+1275.0%) | $1.08 M(-42.8%) |
| Jan 2019 | - | $20.00 K(-91.0%) | $1.89 M(-7.9%) |
| Oct 2018 | - | $221.00 K(-60.9%) | $2.05 M(+9.0%) |
| July 2018 | - | $565.00 K(-47.9%) | $1.88 M(+31.9%) |
| Apr 2018 | $1.43 M(+1828.4%) | $1.08 M(+495.6%) | $1.43 M(+316.0%) |
| Jan 2018 | - | $182.00 K(+256.9%) | $343.00 K(+113.0%) |
| Oct 2017 | - | $51.00 K(-53.6%) | $161.00 K(+46.4%) |
| July 2017 | - | $110.00 K(>+9900.0%) | $110.00 K(-91.8%) |
| Apr 2017 | $74.00 K | - | - |
| Sept 2016 | - | $0.00(-100.0%) | $1.34 M(-1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $61.00 K(-66.8%) | $1.36 M(-1.3%) |
| Apr 2016 | $11.00 K(-99.2%) | - | - |
| Mar 2016 | - | $184.00 K(-83.2%) | $1.38 M(+0.3%) |
| Dec 2015 | $1.37 M(+999.2%) | $1.09 M(+5109.5%) | $1.37 M(+286.0%) |
| Sept 2015 | - | $21.00 K(-73.4%) | $356.00 K(+4.1%) |
| June 2015 | - | $79.00 K(-56.1%) | $342.00 K(+1.2%) |
| Apr 2015 | $125.00 K(-21.4%) | - | - |
| Mar 2015 | - | $180.00 K(+136.8%) | $338.00 K(+112.6%) |
| Dec 2014 | $159.00 K(+783.3%) | $76.00 K(+985.7%) | $159.00 K(+91.6%) |
| Sept 2014 | - | $7000.00(-90.7%) | $83.00 K(+9.2%) |
| June 2014 | - | $75.00 K(+7400.0%) | $76.00 K(+7500.0%) |
| Mar 2014 | - | $1000.00 | $1000.00 |
| Dec 2013 | $18.00 K(-80.2%) | - | - |
| Dec 2012 | $91.00 K | - | - |
FAQ
- What is the all time high annual CAPEX for KalVista Pharmaceuticals?
- What is the all time high quarterly CAPEX for KalVista Pharmaceuticals?
- What is the all time high TTM CAPEX for KalVista Pharmaceuticals?
What is the all time high annual CAPEX for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual capital expenditures is $1.43 M
What is the all time high quarterly CAPEX for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly capital expenditures is $1.09 M
What is the all time high TTM CAPEX for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM capital expenditures is $2.05 M